All Stories

  1. Characterization of SF3B1 role in prolactin-secreting pituitary tumors

    Article • Endocrine Related Cancer, June 2026, Bioscientifica

    Marta Korbonits

  2. Patients With Pituitary Neuroendocrine Tumours Requiring Neurosurgery –Who Is Referring Them?

    Article • Clinical Endocrinology, January 2026, Wiley

    Marta Korbonits

  3. Effects of Hypopituitarism Due to Sheehan's Syndrome on Bone Mineral Density: A Multicentric Study in Asian Indians

    Article • Clinical Endocrinology, December 2025, Wiley

    Marta Korbonits

  4. New directions in MEN1 management: navigating the new clinical practice guidelines

    Article • European Journal of Endocrinology, November 2025, Oxford University Press (OUP)

    Marta Korbonits

  5. Bone Density, Microarchitecture, and Geometry Assessment in Patients with Pachydermoperiostosis Using Second-Generation High-Resolution Peripheral Quantitative Computed Tomography: A Case–Control Study

    Article • Calcified Tissue International, August 2025, Springer Science + Business Media

    Marta Korbonits

  6. A Novel De Novo Nonsense Pathogenic Variant in IGSF1 Resulting in Central Hypothyroidism and Transient GH Deficiency

    Article • JCEM Case Reports, March 2025, Endocrine Society

    Marta Korbonits

  7. RET signalling in the pituitary: a double-edged sword for differentiation, apoptosis and therapeutic strategies in acromegaly

    Article • Endocrine Related Cancer, January 2025, Bioscientifica

    Marta Korbonits

  8. Clinical features of acromegaly

    Article • January 2025, Elsevier

    Marta Korbonits

  9. Bone mineral density, turnover, and microarchitecture assessed by second-generation high-resolution peripheral quantitative computed tomography in patients with Sheehan’s syndrome

    Article • Osteoporosis International, March 2024, Springer Science + Business Media

    Marta Korbonits

  10. Tall stature and gigantism in adult patients with acromegaly

    Article • European Journal of Endocrinology, February 2024, Oxford University Press (OUP)

    Marta Korbonits

  11. Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases

    Article • Nature Reviews Endocrinology, February 2024, Springer Science + Business Media

    Marta Korbonits

  12. Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations

    Article • Nature Reviews Endocrinology, February 2024, Springer Science + Business Media

    Marta Korbonits

  13. Multiple Endocrine Neoplasia and Familial Isolated Pituitary Adenoma in the Paediatric Population

    Article • January 2024, Springer Science + Business Media

    Marta Korbonits

  14. Genetic Testing in Hereditary Pituitary Tumors

    Article • Archives of Medical Research, December 2023, Elsevier

    Marta Korbonits

  15. Pharmacological and Genetic Disruption of C-Type Natriuretic Peptide (nppcl) Expression in Zebrafish (Danio rerio) Causes Stunted Growth during Development

    Article • International Journal of Molecular Sciences, August 2023, MDPI AG

    Marta Korbonits

  16. Live Fast, Die Young?

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2023, Endocrine Society

    Marta Korbonits

  17. Effective Long-term Pediatric Pegvisomant Monotherapy to Final Height in X-linked Acrogigantism

    Article • JCEM Case Reports, May 2023, Endocrine Society

    Marta Korbonits

  18. Tumour microenvironment and pituitary tumour behaviour

    Article • Journal of Endocrinological Investigation, April 2023, Springer Science + Business Media

    Marta Korbonits

  19. Insulinomatosis: new aspects

    Article • Endocrine Related Cancer, March 2023, Bioscientifica

    Marta Korbonits

  20. Evaluating home injection compared with healthcare-setting injection of somatostatin analogs: a systematic literature review

    Article • Endocrine, November 2022, Springer Science + Business Media

    Prof Wouter WW de Herder, Marta Korbonits

  21. Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours

    Article • Endocrine Related Cancer, October 2022, Bioscientifica

    Marta Korbonits

  22. AIP: A double agent? The tissue-specific role of AIP as a tumour suppressor or as an oncogene

    Article • British Journal of Cancer, September 2022, Springer Science + Business Media

    Marta Korbonits

  23. Ockham’s Razor for a Retinal Lesion and Acromegaly and Breaking the Vicious Circle

    Article • Journal of the Endocrine Society, June 2022, Endocrine Society

    Marta Korbonits

  24. Glucose and lipid metabolism abnormalities in Cushing’s syndrome

    Article • Journal of Neuroendocrinology, April 2022, Wiley

    Marta Korbonits

  25. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2022, Endocrine Society

    Professor Gudmundur Johannsson, Marta Korbonits

  26. Temozolomide Nonresponsiveness in Aggressive Prolactinomas and Carcinomas: Management and Outcomes

    Article • Journal of the Endocrine Society, December 2021, Endocrine Society

    Marta Korbonits

  27. Approach to the Patient With Pseudoacromegaly

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2021, Endocrine Society

    Marta Korbonits

  28. Sex-biased islet β cell dysfunction is caused by the MODY MAFA S64F variant by inducing premature aging and senescence in males

    Article • Cell Reports, October 2021, Elsevier

    Marta Korbonits

  29. Serum Inflammation-based Scores in Endocrine Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2021, Endocrine Society

    Marta Korbonits

  30. Genetics of Acromegaly and Gigantism

    Article • Journal of Clinical Medicine, March 2021, MDPI AG

    Marta Korbonits

  31. Molecular characterization of DICER1-mutated pituitary blastoma

    Article • Acta Neuropathologica, March 2021, Springer Science + Business Media

    Marta Korbonits

  32. The clinical aspects of pituitary tumour genetics

    Article • Endocrine, February 2021, Springer Science + Business Media

    Marta Korbonits

  33. Patients with rare endocrine conditions have corresponding views on unmet needs in clinical research

    Article • Endocrine, February 2021, Springer Science + Business Media

    Marta Korbonits

  34. Pre-operative serum inflammation-based scores in patients with pituitary adenomas

    Article • Pituitary, November 2020, Springer Science + Business Media

    Marta Korbonits

  35. Update on the Genetics of Pituitary Tumors

    Article • Endocrinology and Metabolism Clinics of North America, September 2020, Elsevier

    Marta Korbonits

  36. The tumour microenvironment of pituitary neuroendocrine tumours

    Article • Frontiers in Neuroendocrinology, July 2020, Elsevier

    Marta Korbonits

  37. Unusual Combination of MEN-1 and the Contiguous Gene Deletion Syndrome of CAH and Ehlers-Danlos Syndrome (CAH-X)

    Article • Journal of the Endocrine Society, June 2020, Endocrine Society

    Marta Korbonits

  38. XAF1 as a modifier of p53 function and cancer susceptibility

    Article • Science Advances, June 2020, American Association for the Advancement of Science

    Professor Berenice B Mendonca, Marta Korbonits

  39. Phenotypic and genotypic features of a large kindred with a germline AIP variant

    Article • Clinical Endocrinology, May 2020, Wiley

    Marta Korbonits

  40. Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial

    Article • The Lancet Diabetes & Endocrinology, April 2020, Elsevier

    Marta Korbonits

  41. Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms

    Article • Endocrine Reviews, March 2020, Endocrine Society

    Marta Korbonits

  42. Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2020, Endocrine Society

    Marta Korbonits

  43. Pachydermoperiostosis mimicking the acral abnormalities of acromegaly

    Article • Endocrine, January 2020, Springer Science + Business Media

    Marta Korbonits

  44. Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours

    Article • Endocrine, December 2019, Springer Science + Business Media

    Marta Korbonits

  45. Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness

    Article • Endocrine Related Cancer, December 2019, Bioscientifica

    Marta Korbonits

  46. Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours

    Article • Acta Neuropathologica Communications, November 2019, Springer Science + Business Media

    Marta Korbonits

  47. Redefining the perioperative stress response: a narrative review

    Article • British Journal of Anaesthesia, November 2019, Elsevier

    Marta Korbonits

  48. Plasma Renin Measurements are Unrelated to Mineralocorticoid Replacement Dose in Patients With Primary Adrenal Insufficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2019, Endocrine Society

    Professor Berenice B Mendonca, Marta Korbonits

  49. Pediatric Parathyroid Carcinoma: A Case Report and Review of the Literature

    Article • Journal of the Endocrine Society, September 2019, Endocrine Society

    Marta Korbonits

  50. Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2019, Endocrine Society

    Marta Korbonits

  51. Acromegaly associated with GIST, non-small cell lung carcinoma, clear cell renal carcinoma, multiple myeloma, medulla oblongata tumour, adrenal adenoma, and follicular thyroid nodules

    Article • Endokrynologia Polska, April 2019, VM Media SP. zo.o VM Group SK

    Marta Korbonits

  52. Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 Degradation

    Article • Cell Reports, April 2019, Elsevier

    Marta Korbonits

  53. Circulating aryl hydrocarbon receptor-interacting protein (AIP) is independent of GH secretion

    Article • Endocrine Connections, April 2019, Bioscientifica

    Marta Korbonits

  54. Phosphodiesterases and cAMP Pathway in Pituitary Diseases

    Article • Frontiers in Endocrinology, March 2019, Frontiers

    Marta Korbonits

  55. Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors

    Article • Oncogene, March 2019, Springer Science + Business Media

    Marta Korbonits

  56. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study

    Article • The Lancet Diabetes & Endocrinology, March 2019, Elsevier

    Marta Korbonits

  57. Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects

    Article • Journal of Endocrinology, February 2019, Bioscientifica

    Marta Korbonits

  58. The current landscape of European registries for rare endocrine conditions

    Article • European Journal of Endocrinology, January 2019, Oxford University Press (OUP)

    Marta Korbonits

  59. Assessment of Cardiavascular Changes following Trans-sphenoidal Surgery in Acromegalic Patients

    Article • Neurology India, January 2019, Medknow

    Marta Korbonits

  60. Genetics of Pituitary Tumours

    Article • January 2019, Springer Science + Business Media

    Marta Korbonits

  61. Proteomic Analysis of the Human Anterior Pituitary Gland

    Article • OMICS A Journal of Integrative Biology, December 2018, SAGE Publications

    Marta Korbonits

  62. Pseudoacromegaly

    Article • Frontiers in Neuroendocrinology, November 2018, Elsevier

    Marta Korbonits

  63. Reduced protein expression of the phosphodiesterases PDE4A4 and PDE4A8 in AIP mutation positive somatotroph adenomas

    Article • Molecular and Cellular Endocrinology, November 2018, Elsevier

    Marta Korbonits

  64. Pituitary Pathology and Gene Expression in Acromegalic Cats

    Article • Journal of the Endocrine Society, October 2018, Endocrine Society

    Marta Korbonits

  65. Coexisting pituitary and non-pituitary gigantism in the same family

    Article • Clinical Endocrinology, October 2018, Wiley

    Marta Korbonits

  66. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature

    Article • Pharmacological Reviews, September 2018, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Marta Korbonits

  67. Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome

    Article • Case Reports in Endocrinology, August 2018, Hindawi Publishing Corporation

    Marta Korbonits

  68. Clinical and Pathological Aspects of Silent Pituitary Adenomas

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2018, Endocrine Society

    Marta Korbonits

  69. Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas

    Article • Oncotarget, June 2018, Impact Journals, LLC

    Marta Korbonits

  70. Macimorelin as a Diagnostic Test for Adult GH Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2018, Endocrine Society

    Marta Korbonits

  71. A novel DICER1 mutation in familial multinodular goitre

    Article • Clinical Endocrinology, May 2018, Wiley

    Marta Korbonits

  72. UPDATE ON THE CLINICOPATHOLOGY OF PITUITARY ADENOMAS

    Article • Endocrine Practice, May 2018, Elsevier

    Marta Korbonits

  73. Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2

    Article • BJS, April 2018, Oxford University Press (OUP)

    Marta Korbonits

  74. In vivo bioassay to test the pathogenicity of missense human AIP variants

    Article • Journal of Medical Genetics, April 2018, BMJ

    Marta Korbonits

  75. De novo HNF1 homeobox B mutation as a cause for chronic, treatment-resistant hypomagnesaemia

    Article • Endocrinology Diabetes and Metabolism Case Reports, March 2018, Bioscientifica

    Marta Korbonits

  76. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target

    Article • Acta Neuropathologica, March 2018, Springer Science + Business Media

    Marta Korbonits

  77. Risk category system to identify pituitary adenoma patients with AIP mutations

    Article • Journal of Medical Genetics, February 2018, BMJ

    Marta Korbonits

  78. MAFA missense mutation causes familial insulinomatosis and diabetes mellitus

    Article • Proceedings of the National Academy of Sciences, January 2018, Proceedings of the National Academy of Sciences

    Marta Korbonits

  79. Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

    Article • European Journal of Endocrinology, January 2018, Bioscientifica

    Professor Gerald Raverot, Professor Gudmundur Johannsson, Marta Korbonits

  80. Cantú syndrome with coexisting familial pituitary adenoma

    Article • Endocrine, January 2018, Springer Science + Business Media

    Marta Korbonits

  81. Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland

    Article • Oncotarget, January 2018, Impact Journals, LLC

    Marta Korbonits, Professor Fulvio D'Acquisto

  82. Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members’ View in anAIPMutation-Positive Family

    Article • International Journal of Endocrinology, January 2018, Hindawi Publishing Corporation

    Marta Korbonits

  83. Metabolic Syndrome in Cushing's Syndrome Patients

    Article • January 2018, Karger Publishers

    Marta Korbonits

  84. Preliminaries

    Article • January 2018, Karger Publishers

    Marta Korbonits

  85. AIP mutations in Brazilian patients with sporadic pituitary adenomas: a single-center evaluation

    Article • Endocrine Connections, October 2017, Bioscientifica

    Marta Korbonits

  86. Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson’s tumor

    Article • European Journal of Endocrinology, October 2017, Bioscientifica

    Prof Marily Theodoropoulou, Marta Korbonits, Luis Gustavo Perez-Rivas

  87. AIP and the somatostatin system in pituitary tumours

    Article • Journal of Endocrinology, August 2017, Bioscientifica

    Marta Korbonits

  88. Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone

    Article • Journal of Endocrinology, August 2017, Bioscientifica

    Rhonda Prisby, Marta Korbonits

  89. Fatal Carney Complex in Siblings Due to De Novo Large Gene Deletion

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2017, Endocrine Society

    Marta Korbonits

  90. Pseudoacromegaly: A Differential Diagnostic Problem for Acromegaly With a Genetic Solution

    Article • Journal of the Endocrine Society, July 2017, Endocrine Society

    Dr Per M Dahlqvist, Professor Gudmundur Johannsson, Marta Korbonits

  91. In-frame seven amino-acid duplication in AIP arose over the last 3000 years, disrupts protein interaction and stability and is associated with gigantism

    Article • European Journal of Endocrinology, June 2017, Bioscientifica

    Marta Korbonits, Professor Lou A Metherell

  92. PRKAR1A mutation causing pituitary-dependent Cushing disease in a patient with Carney complex

    Article • European Journal of Endocrinology, May 2017, Bioscientifica

    Marta Korbonits

  93. Cabergoline-related impulse control disorder in an adolescent with a giant prolactinoma

    Article • Clinical Endocrinology, April 2017, Wiley

    Ananth Shankar, Marta Korbonits

  94. A unique haplotype of RCCX copy number variation: from the clinics of congenital adrenal hyperplasia to evolutionary genetics

    Article • European Journal of Human Genetics, April 2017, Springer Science + Business Media

    Marta Korbonits

  95. Pituitary Carcinoma in a Patient with an SDHB Mutation

    Article • Endocrine Pathology, March 2017, Springer Science + Business Media

    Marta Korbonits

  96. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal

    Article • Endocrine Related Cancer, March 2017, Bioscientifica

    Sylvia Asa, Professor Gerald Raverot, Marta Korbonits

  97. Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening

    Article • Expert Review of Endocrinology & Metabolism, March 2017, Taylor & Francis

    Marta Korbonits

  98. Genetic Aspects of Pituitary Adenomas

    Article • Endocrinology and Metabolism Clinics of North America, March 2017, Elsevier

    Marta Korbonits

  99. Renin-Angiotensin System Blockade Improves Cardiac Indices in Acromegaly Patients

    Article • Experimental and Clinical Endocrinology & Diabetes, February 2017, Thieme Publishing Group

    Marta Korbonits

  100. Social, educational and vocational outcomes in patients with childhood-onset and young-adult-onset growth hormone deficiency

    Article • Clinical Endocrinology, February 2017, Wiley

    Marta Korbonits

  101. The genetic background of acromegaly

    Article • Pituitary, February 2017, Springer Science + Business Media

    Marta Korbonits

  102. Succinate Dehydrogenase B (SDHB)-Associated Bladder Paragangliomas

    Article • Clinical Genitourinary Cancer, February 2017, Elsevier

    Marta Korbonits

  103. Pachydermoperiostosis Masquerading as Acromegaly

    Article • Journal of the Endocrine Society, January 2017, Endocrine Society

    ashley grossman, Marta Korbonits

  104. Metformin prevents metabolic side effects during systemic glucocorticoid treatment

    Article • European Journal of Endocrinology, January 2017, Bioscientifica

    Marta Korbonits

  105. Diagnostic challenges and management of a patient with acromegaly due to ectopic growth hormone-releasing hormone secretion from a bronchial carcinoid tumour

    Article • Endocrinology Diabetes and Metabolism Case Reports, January 2017, Bioscientifica

    Marta Korbonits, Dr Robert D Murray

  106. Echocardiographic improvements following transsphenoidal surgery for acromegaly

    Article • Neurology India, January 2017, Medknow

    Marta Korbonits

  107. Genetics of pituitary adenomas

    Article • Neurology India, January 2017, Medknow

    Marta Korbonits

  108. Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas

    Article • Pathology & Oncology Research, December 2016, Springer Science + Business Media

    Marta Korbonits

  109. Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers

    Article • Clinical Endocrinology, October 2016, Wiley

    Marta Korbonits

  110. The clinical, pathological and molecular differences between sparsely and densely granulated somatotroph adenomas

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  111. Glioma in an AIP mutation carrier patient

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  112. Pseudoacromegaly - a differential diagnostic problem for acromegaly

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  113. Olfactory neuroblastoma: a multi centre clinical and pathological review

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  114. Metformin alters an anti-proliferative effect of Mitotane in a human adrenocortical cancer (H295R) cell line: preliminary results

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  115. The role of the microenvironment in the invasive phenotype of familial pituitary tumours

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  116. Polymorphism or mutation? - The role of the R304Q missense AIP mutation in the predisposition to pituitary adenoma

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits, Adrian Daly

  117. ESR2 mutations in RET mutation-negative familial medullary thyroid carcinoma

    Article • Endocrine Abstracts, October 2016, Bioscientifica

    Marta Korbonits

  118. Novel Genetic Causes of Pituitary Adenomas

    Article • Clinical Cancer Research, October 2016, American Association for Cancer Research (AACR)

    Marta Korbonits

  119. Increased Population Risk ofAIP-Related Acromegaly and Gigantism in Ireland

    Article • Human Mutation, October 2016, Wiley

    Marta Korbonits

  120. Gigantism: X-linked acrogigantism and GPR101 mutations

    Article • Growth Hormone & IGF Research, October 2016, Elsevier

    Marta Korbonits

  121. Characterisation of myocardial structure and function in adult-onset growth hormone deficiency using cardiac magnetic resonance

    Article • Endocrine, August 2016, Springer Science + Business Media

    Marta Korbonits

  122. Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With MissenseAIPMutations

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2016, Endocrine Society

    Professor Fulvio D'Acquisto, Marta Korbonits

  123. Signaling network map of the aryl hydrocarbon receptor

    Article • Journal of Cell Communication and Signaling, July 2016, Springer Science + Business Media

    Marta Korbonits, Professor Premendu Prakash Mathur

  124. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study

    Article • Acta Neuropathologica Communications, June 2016, Springer Science + Business Media

    Marta Korbonits

  125. AIP inactivation leads to pituitary enlargement in the Zebrafish embryo model

    Article • Endocrine Abstracts, May 2016, Bioscientifica

    Marta Korbonits

  126. The Drosophila AIP orthologue is essential for actin cytoskeleton stabilisation and cell adhesion

    Article • Endocrine Abstracts, May 2016, Bioscientifica

    Marta Korbonits

  127. cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors

    Article • Endocrine Related Cancer, May 2016, Bioscientifica

    Marta Korbonits

  128. SomaticGPR101Duplication Causing X-Linked Acrogigantism (XLAG)—Diagnosis and Management

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2016, Endocrine Society

    Marta Korbonits

  129. Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction

    Article • Journal of the American College of Cardiology, May 2016, Elsevier

    Marta Korbonits

  130. AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience

    Article • Endocrine, March 2016, Springer Science + Business Media

    Marta Korbonits

  131. Clinicopathologic features of familial pituitary adenomas

    Article • Diagnostic Histopathology, March 2016, Elsevier

    Marta Korbonits

  132. Cancerous leptomeningitis and familial congenital hypopituitarism

    Article • Endocrine, February 2016, Springer Science + Business Media

    Marta Korbonits

  133. AIP and the somatostatin signalling in pituitary tumours

    Article • Endocrine Abstracts, February 2016, Bioscientifica

    Marta Korbonits

  134. Can immediate postoperative random growth hormone levels predict long-term cure in patients with acromegaly?

    Article • Neurology India, January 2016, Medknow

    Marta Korbonits, Prof NARESH SACHDEVA

  135. Endocrine Tumor Genetics: Challenging Issues

    Article • January 2016, Endocrine Society

    Marta Korbonits

  136. Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity

    Article • World Journal of Diabetes, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Marta Korbonits

  137. Diagnosis of Acromegaly

    Article • January 2016, Elsevier

    Marta Korbonits

  138. Clinical Features of Acromegaly☆

    Article • January 2016, Elsevier

    Marta Korbonits

  139. Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly

    Article • European Journal of Endocrinology, December 2015, Bioscientifica

    Dr Niki Karavitaki, Professor Christian J. Strasburger, Marta Korbonits

  140. Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways

    Article • PLOS One, December 2015, PLOS

    Marta Korbonits

  141. Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study

    Article • European Journal of Endocrinology, November 2015, Bioscientifica

    Marta Korbonits

  142. Childhood somatotroph pituitary adenomas due to aryl hydrocarbon receptor interacting protein (AIP) gene mutations

    Article • Endocrine Abstracts, November 2015, Bioscientifica

    Marta Korbonits

  143. Pegvisomant treatment for X-linked acrogigantism syndrome

    Article • Endocrine Abstracts, November 2015, Bioscientifica

    Marta Korbonits

  144. Achieving a consensus on managing idiopathic thickening of the pituitary stalk through a national multidisciplinary forum, meeting virtually

    Article • Endocrine Abstracts, November 2015, Bioscientifica

    Marta Korbonits, Ian Kamaly-Asl

  145. In vitroeffects of Imatinib on somatotrophinoma cell line

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Marta Korbonits, Prof NARESH SACHDEVA

  146. Silencing of aryl hydrocarbon receptor protein (AIP) up-regulates the small Rho GTPase, CDC42

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Marta Korbonits

  147. Novel targeted treatment combinations for malignant neuroendocrine tumour olfactory neuroblastoma

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Marta Korbonits

  148. Potential molecular mechanism of AIP-mediated cellular invasion

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Marta Korbonits

  149. The effect of AIP on AHR transcriptional activity: implications forAIPmutations pathogenicity

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Marta Korbonits

  150. Investigation of the invasive phenotype of AIP-mutated pituitary adenomas

    Article • Endocrine Abstracts, October 2015, Bioscientifica

    Marta Korbonits

  151. The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study

    Article • European Journal of Endocrinology, September 2015, Bioscientifica

    Marta Korbonits

  152. Histopathology and molecular characterisation of intrauterine-diagnosed congenital craniopharyngioma

    Article • Pituitary, September 2015, Springer Science + Business Media

    Marta Korbonits

  153. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis inAIPMutation Carriers

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2015, Endocrine Society

    Dr Warrick J Inder, Dr Niki Karavitaki, Marta Korbonits

  154. The effects of chronic candesartan treatment on cardiac and hepatic adenosine monophosphate-activated protein kinase in rats submitted to surgical stress

    Article • Journal of the Renin-Angiotensin-Aldosterone System, September 2015, SAGE Publications

    Marta Korbonits

  155. Prostatic hyperplasia in acromegaly

    Article • European Journal of Endocrinology, July 2015, Bioscientifica

    Dr Balan Louis Gaspar, Marta Korbonits

  156. Treatment-resistant pediatric giant prolactinoma and multiple endocrine neoplasia type 1

    Article • International Journal of Pediatric Endocrinology, July 2015, Springer Science + Business Media

    Marta Korbonits

  157. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2015, Endocrine Society

    Marta Korbonits, Luis Gustavo Perez-Rivas

  158. 15 YEARS OF PARAGANGLIOMA: The association of pituitary adenomas and phaeochromocytomas or paragangliomas

    Article • Endocrine Related Cancer, June 2015, Bioscientifica

    Marta Korbonits

  159. Metabolic comorbidities in Cushing's syndrome

    Article • European Journal of Endocrinology, June 2015, Bioscientifica

    Marta Korbonits

  160. Ghrelin

    Article • Molecular Metabolism, June 2015, Elsevier

    Marta Korbonits, Inge Depoortere

  161. Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter

    Article • PLOS One, May 2015, PLOS

    Marta Korbonits

  162. The ubiquitin-specific protease 8 gene is frequently mutated in adenomas causing Cushing's disease

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Luis Gustavo Perez-Rivas, Marta Korbonits

  163. Pituitary apoplexy in GH-deficient adults treated with GH - a KIMS database retrospective study

    Article • Endocrine Abstracts, May 2015, Bioscientifica

    Marta Korbonits

  164. Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2015, Endocrine Society

    Marta Korbonits

  165. Excessive Growth Hormone Expression in Male GH Transgenic Mice Adversely Alters Bone Architecture and Mechanical Strength

    Article • Endocrinology, April 2015, Endocrine Society

    Marta Korbonits

  166. Kallmann syndrome patient with gender dysphoria, multiple sclerosis, and thrombophilia

    Article • Endocrine, March 2015, Springer Science + Business Media

    Marta Korbonits

  167. Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2015, Endocrine Society

    Dr Christopher A Wassif, PROF CESAR L BOGUSZEWSKI, Marta Korbonits

  168. Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas

    Article • PLOS One, February 2015, PLOS

    Marta Korbonits

  169. Evaluation of genotype–phenotype relationships in patients referred for endocrine assessment in suspected Pendred syndrome

    Article • European Journal of Endocrinology, February 2015, Bioscientifica

    Marta Korbonits

  170. Prostatic hyperplasia in acromegaly, a myth or reality: a case–control study

    Article • European Journal of Endocrinology, February 2015, Bioscientifica

    Marta Korbonits

  171. GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database

    Article • January 2015, Bioscientifica

    Marta Korbonits

  172. An unusual case of an ACTH-secreting macroadenoma with a germline variant in the aryl hydrocarbon receptor-interacting protein (AIP) gene

    Article • Endocrinology Diabetes and Metabolism Case Reports, January 2015, Bioscientifica

    Claus H. Gravholt, Marta Korbonits, Professor Jens Otto Lunde Jorgensen

  173. Multi-parametric cardiovascular magnetic resonance imaging detects subclinical myocardial involvement in patients diagnosed with phaeochromocytoma

    Article • Journal of Cardiovascular Magnetic Resonance, January 2015, Springer Science + Business Media

    Dr Niki Karavitaki, Marta Korbonits

  174. A 25-Year-Old Woman with Headache and Joint Pain

    Article • January 2015, Springer Science + Business Media

    Marta Korbonits

  175. Clinical profile and outcome of patients with acromegaly according to the 2014 consensus guidelines: Impact of a multi-disciplinary team

    Article • Neurology India, January 2015, Medknow

    Marta Korbonits, Prof NARESH SACHDEVA

  176. The role of ghrelin in weight-regulation disorders: Implications in clinical practice

    Article • HORMONES, December 2014, Hellenic Endocrine Society

    Marta Korbonits

  177. Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas

    Article • European Journal of Endocrinology, December 2014, Bioscientifica

    Dr Niki Karavitaki, Marta Korbonits

  178. Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort

    Article • European Journal of Endocrinology, November 2014, Bioscientifica

    Dr Niki Karavitaki, Marta Korbonits

  179. Adrenal cancer in neurofibromatosis type 1: case report and DNA analysis

    Article • Endocrinology Diabetes and Metabolism Case Reports, November 2014, Bioscientifica

    Marta Korbonits

  180. Paediatric pituitary adenomas: rare, complex, and by no means benign

    Article • Endocrine Abstracts, October 2014, Bioscientifica

    Marta Korbonits

  181. Common Genetic Variants of the Human Steroid 21-Hydroxylase Gene (CYP21A2) Are Related to Differences in Circulating Hormone Levels

    Article • PLOS One, September 2014, PLOS

    Marta Korbonits

  182. Combination of 13-CisRetinoic Acid and Lovastatin: Marked Antitumor Potential In Vivo in a Pheochromocytoma Allograft Model in Female Athymic Nude Mice

    Article • Endocrinology, July 2014, Endocrine Society

    Marta Korbonits

  183. Effects of Long-term Growth Hormone Replacement in Adults With Growth Hormone Deficiency Following Cure of Acromegaly: A KIMS Analysis

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2014, Endocrine Society

    Professor Ulla Feldt-Rasmussen, Professor Gudmundur Johannsson, Marta Korbonits

  184. 122 Cardiac Abnormalities are Common in Patients Diagnosed with Phaeochromocytoma as Detected by Cardiovascular Magnetic Resonance Imaging

    Article • Heart, May 2014, BMJ

    Dr Niki Karavitaki, Marta Korbonits

  185. Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations

    Article • Acta Neuropathologica, May 2014, Springer Science + Business Media

    Marta Korbonits

  186. Human AIP gene rescue lethality in a Drosophila melanogaster knockout model of AIP orthologue

    Article • Endocrine Abstracts, April 2014, Bioscientifica

    Marta Korbonits

  187. The anti-proliferative effect of anti-EGFR tyrosine kinase inhibitor in combination with mitotane on H295R adrenocortical cancer cells

    Article • Endocrine Abstracts, April 2014, Bioscientifica

    Marta Korbonits

  188. Clinical Experience in the Screening and Management of a Large Kindred With Familial Isolated Pituitary Adenoma Due to an Aryl Hydrocarbon Receptor Interacting Protein (AIP) Mutation

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2014, Endocrine Society

    Marta Korbonits

  189. Analysis of the AIP gene promoter

    Article • Endocrine Abstracts, March 2014, Bioscientifica

    Marta Korbonits

  190. Kallmann syndrome, gender dysphoria, thrombophilia and multiple sclerosis: a complex case report

    Article • Endocrine Abstracts, March 2014, Bioscientifica

    Marta Korbonits, Richard Quinton

  191. High incidence of cardiac involvement in patients diagnosed with phaeochromocytoma: a clinical study using cardiovascular magnetic resonance imaging

    Article • Endocrine Abstracts, March 2014, Bioscientifica

    Dr Niki Karavitaki, Dr Theodoros Karamitsos, Marta Korbonits

  192. RET mutation negative familial medullary thyroid carcinoma: four families and literature review

    Article • Endocrine Abstracts, March 2014, Bioscientifica

    Marta Korbonits

  193. Pre-clinical assessment of the impact of Erlotinib on adrenocortical cancer cells proliferation

    Article • Endocrine Abstracts, March 2014, Bioscientifica

    Marta Korbonits

  194. Epidemiology and etiopathogenesis of pituitary adenomas

    Article • Journal of Neuro-Oncology, January 2014, Springer Science + Business Media

    Marta Korbonits

  195. Metformin—mode of action and clinical implications for diabetes and cancer

    Article • Nature Reviews Endocrinology, January 2014, Springer Science + Business Media

    Marta Korbonits

  196. Preface

    Article • January 2014, Elsevier

    Marta Korbonits

  197. Familial pituitary tumors

    Article • January 2014, Elsevier

    Marta Korbonits

  198. Characterization of SNARE Proteins in Human Pituitary Adenomas: Targeted Secretion Inhibitors as a New Strategy for the Treatment of Acromegaly?

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2013, Endocrine Society

    Marta Korbonits

  199. MicroRNAs: Suggested role in pituitary adenoma pathogenesis

    Article • Journal of Endocrinological Investigation, November 2013, Springer Science + Business Media

    Marta Korbonits

  200. Effects of smoking cessation on  -cell function, insulin sensitivity, body weight, and appetite

    Article • October 2013, Bioscientifica

    Marta Korbonits

  201. The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release

    Article • The FASEB Journal, August 2013, Federation of American Societies For Experimental Biology (FASEB)

    Marta Korbonits

  202. CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus

    Article • July 2013, Bioscientifica

    Marta Korbonits

  203. A Comprehensive Next Generation Sequencing–Based Genetic Testing Strategy To Improve Diagnosis of Inherited Pheochromocytoma and Paraganglioma

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2013, Endocrine Society

    Marta Korbonits

  204. Fasting and postprandial liver glycogen content in patients with type 1 diabetes mellitus after successful pancreas-kidney transplantation with systemic venous insulin delivery

    Article • Clinical Endocrinology, May 2013, Wiley

    Marta Korbonits

  205. Novel pathway for somatostatin analogs in patients with acromegaly

    Article • Trends in Endocrinology and Metabolism, May 2013, Elsevier

    Marta Korbonits

  206. GH excess in bGH transgenic mice adversely affects bone density, architecture and quality

    Article • Bone Abstracts, May 2013, Bioscientifica

    Marta Korbonits

  207. AIP (aryl hydrocarbon receptor interacting protein)

    Article • Atlas of Genetics and Cytogenetics in Oncology and Haematology, May 2013, INIST-CNRS

    Marta Korbonits

  208. Gene expression profiling of familial and sporadic pituitary adenomas

    Article • Endocrine Abstracts, April 2013, Bioscientifica

    Marta Korbonits

  209. Genetic and clinical characteristics of Serbian FIPA families

    Article • Endocrine Abstracts, April 2013, Bioscientifica

    Marta Korbonits

  210. Drosophila melanogasteras a model organism to study aryl hydrocarbon receptor interacting protein gene function

    Article • Endocrine Abstracts, April 2013, Bioscientifica

    Marta Korbonits

  211. A Novel Mutation in the Upstream Open Reading Frame of the CDKN1B Gene Causes a MEN4 Phenotype

    Article • PLoS Genetics, March 2013, PLOS

    Marta Korbonits

  212. Familial Pituitary Adenomas

    Article • March 2013, Wiley

    Marta Korbonits

  213. Genes and giants

    Article • Endocrine Abstracts, March 2013, Bioscientifica

    Marta Korbonits

  214. De Novo HNF1b mutation as a cause for chronic treatment-resistant hypomagnesaemia

    Article • Endocrine Abstracts, March 2013, Bioscientifica

    Marta Korbonits

  215. Excessive GH expression in bGH transgenic mice adversely alters bone architecture and quality

    Article • Endocrine Abstracts, March 2013, Bioscientifica

    Marta Korbonits

  216. The role of microRNA miR-34a in the regulation of aryl hydrocarbon receptor interacting protein

    Article • Endocrine Abstracts, March 2013, Bioscientifica

    Marta Korbonits

  217. Invasion signature' revealed by the analysis of AIP positive and AIP mutation negative human pituitary adenomas

    Article • Endocrine Abstracts, March 2013, Bioscientifica

    Marta Korbonits

  218. Creation of a locus-specific database for AIP mutations

    Article • Endocrine Abstracts, March 2013, Bioscientifica

    Marta Korbonits

  219. Genetics of the Ghrelin System

    Article • January 2013, Karger Publishers

    Marta Korbonits

  220. Genetics of Pituitary Adenomas

    Article • January 2013, Karger Publishers

    Marta Korbonits

  221. Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism

    Article • Molecular and Cellular Endocrinology, January 2013, Elsevier

    Marta Korbonits

  222. Structure of the TPR Domain of AIP: Lack of Client Protein Interaction with the C-Terminal α-7 Helix of the TPR Domain of AIP Is Sufficient for Pituitary Adenoma Predisposition

    Article • PLOS One, December 2012, PLOS

    Marta Korbonits, Dr Chrisostomos Prodromou

  223. Familial isolated pituitary adenomas: An emerging clinical entity

    Article • Journal of Endocrinological Investigation, December 2012, Springer Science + Business Media

    Marta Korbonits

  224. ACTH-secreting Crooke cell carcinoma of the pituitary

    Article • European Journal of Clinical Investigation, November 2012, Wiley

    Marta Korbonits

  225. Genetic studies in a coexistence of acromegaly, pheochromocytoma, gastrointestinal stromal tumor (GIST) and thyroid follicular adenoma

    Article • Arquivos Brasileiros de Endocrinologia & Metabologia, November 2012, FapUNIFESP (SciELO)

    PROF CESAR L BOGUSZEWSKI, Marta Korbonits

  226. 2.7 Expression of a subset of microRNAs in clinically non-functioning pituitary adenomas correlates with tumor size

    Article • September 2012, De Gruyter

    Marta Korbonits

  227. Familial pituitary adenomas – who should be tested for AIP mutations?

    Article • Clinical Endocrinology, August 2012, Wiley

    Marta Korbonits

  228. Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2012, Endocrine Society

    Dr Niki Karavitaki, Marta Korbonits

  229. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro

    Article • AJP Endocrinology and Metabolism, July 2012, American Physiological Society

    Marta Korbonits

  230. Oncogene-induced senescence in pituitary adenomas and carcinomas

    Article • HORMONES, July 2012, Hellenic Endocrine Society

    Marta Korbonits

  231. Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines

    Article • June 2012, Bioscientifica

    Marta Korbonits, ashley grossman

  232. Mice lacking AMP-activated protein kinase  1 catalytic subunit have increased bone remodelling and modified skeletal responses to hormonal challenges induced by ovariectomy and intermittent PTH treatment

    Article • June 2012, Bioscientifica

    Marta Korbonits

  233. Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide

    Article • May 2012, Bioscientifica

    Dr Niki Karavitaki, Marta Korbonits

  234. Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis

    Article • Human Mutation, May 2012, Wiley

    Marta Korbonits

  235. Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor

    Article • Pituitary, April 2012, Springer Science + Business Media

    Marta Korbonits

  236. Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker

    Article • Stress, January 2012, Taylor & Francis

    Marta Korbonits

  237. Ghrelin Regulation of AMPK in the Hypothalamus and Peripheral Tissues

    Article • January 2012, Springer Science + Business Media

    Marta Korbonits

  238. Measurement of AMP-Activated Protein Kinase Activity and Expression in Response to Ghrelin

    Article • January 2012, Elsevier

    Marta Korbonits

  239. Cardiovascular changes in patients with adult-onset growth hormone deficiency assessed by CMR

    Article • Journal of Cardiovascular Magnetic Resonance, January 2012, Springer Science + Business Media

    Marta Korbonits, Professor Steffen E Petersen

  240. Cardiovascular changes in patients with acromegaly assessed by CMR

    Article • Journal of Cardiovascular Magnetic Resonance, January 2012, Springer Science + Business Media

    Marta Korbonits, Professor Steffen E Petersen

  241. Genetic studies on the ghrelin, growth hormone secretagogue receptor (GHSR) and ghrelin O-acyl transferase (GOAT) genes

    Article • Peptides, November 2011, Elsevier

    Marta Korbonits

  242. The Immunophilin-Like Protein XAP2 Is a Negative Regulator of Estrogen Signaling through Interaction with Estrogen Receptor α

    Article • PLOS One, October 2011, PLOS

    Marta Korbonits

  243. Ghrelin in obesity and endocrine diseases

    Article • Molecular and Cellular Endocrinology, June 2011, Elsevier

    Marta Korbonits

  244. miR-107 Is Overexpressed in Pituitary Adenomas and Inhibits the Expression of Aryl Hydrocarbon Receptor-Interacting Protein (AIP)

    Article • June 2011, Endocrine Society

    Marta Korbonits

  245. Familial isolated pituitary adenoma syndrome

    Article • Orvosi Hetilap, May 2011, Akademiai Kiado

    Marta Korbonits

  246. Specific electrocardiographic features associated with Cushing’s disease

    Article • Clinical Endocrinology, April 2011, Wiley

    Marta Korbonits

  247. AIP and its interacting partners

    Article • Journal of Endocrinology, March 2011, Bioscientifica

    Marta Korbonits

  248. WITHDRAWN: Ghrelin in obesity and endocrine diseases

    Article • Molecular and Cellular Endocrinology, March 2011, Elsevier

    Marta Korbonits

  249. The ghrelin/GOAT/GHS-R system and energy metabolism

    Article • Reviews in Endocrine and Metabolic Disorders, February 2011, Springer Science + Business Media

    Marta Korbonits

  250. AIPMutation in Pituitary Adenomas in the 18th Century and Today

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2011, New England Journal of Medicine (NEJM/MMS)

    Marta Korbonits

  251. 2.3.11 Acromegaly

    Article • January 2011, Oxford University Press (OUP)

    Marta Korbonits

  252. The expression of ghrelin O-acyltransferase (GOAT) in human tissues

    Article • Endocrine Journal, January 2011, Japan Endocrine Society

    Marta Korbonits

  253. Mechanisms of metformin action on glucose transport and metabolism in human adipocytes

    Article • Biochemical Pharmacology, December 2010, Elsevier

    Marta Korbonits

  254. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas

    Article • Pituitary, November 2010, Springer Science + Business Media

    Marta Korbonits

  255. Familial isolated pituitary adenomas experience at a single center: clinical importance of AIP mutation screening

    Article • Arquivos Brasileiros de Endocrinologia & Metabologia, November 2010, FapUNIFESP (SciELO)

    Marta Korbonits

  256. Down-Regulation of Wee1 Kinase by a Specific Subset of microRNA in Human Sporadic Pituitary Adenomas

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2010, Endocrine Society

    Marta Korbonits

  257. AIP gene and familial isolated pituitary adenomas

    Article • Molecular and Cellular Endocrinology, September 2010, Elsevier

    Marta Korbonits

  258. Cyclins and their related proteins in pituitary tumourigenesis

    Article • Molecular and Cellular Endocrinology, September 2010, Elsevier

    Marta Korbonits

  259. Role of the aryl hydrocarbon receptor-interacting protein in familial isolated pituitary adenoma

    Article • Expert Review of Endocrinology & Metabolism, September 2010, Taylor & Francis

    Marta Korbonits

  260. Down-Regulation of Wee1 Kinase by a Specific Subset of microRNAs in Human Sporadic Pituitary Adenomas

    Article • Molecular Endocrinology, September 2010, Endocrine Society

    Marta Korbonits

  261. Alterations in Adipose Tissue during Critical Illness

    Article • American Review of Respiratory Disease, August 2010, American Thoracic Society

    Marta Korbonits

  262. Treatment of acromegaly

    Article • Orvosi Hetilap, August 2010, Akademiai Kiado

    Marta Korbonits

  263. AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass

    Article • Bone, August 2010, Elsevier

    Marta Korbonits

  264. Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA)

    Article • Trends in Endocrinology and Metabolism, July 2010, Elsevier

    Marta Korbonits

  265. AMP-activated protein kinase (AMPK) regulates in vitro bone formation and bone mass in vivo

    Article • Bone, June 2010, Elsevier

    Marta Korbonits

  266. MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas

    Article • Endocrine, May 2010, Springer Science + Business Media

    Marta Korbonits

  267. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families

    Article • Human Mutation, May 2010, Wiley

    Marta Korbonits

  268. Ghrelin’s Role as a Major Regulator of Appetite and Its Other Functions in Neuroendocrinology

    Article • January 2010, Elsevier

    Marta Korbonits

  269. Molecular Genetics of the Aip Gene in Familial Pituitary Tumorigenesis

    Article • January 2010, Elsevier

    Marta Korbonits

  270. PL10 The curious case of ghrelin

    Article • Growth Hormone & IGF Research, January 2010, Elsevier

    Marta Korbonits

  271. Analysis of IMP3 Expression in Normal and Neoplastic Human Pituitary Tissues

    Article • Endocrine Pathology, November 2009, Springer Science + Business Media

    Marta Korbonits

  272. Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists

    Article • European Journal of Endocrinology, September 2009, Bioscientifica

    Marta Korbonits

  273. AMPK as a mediator of hormonal signalling

    Article • Journal of Molecular Endocrinology, July 2009, Bioscientifica

    Marta Korbonits

  274. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors

    Article • Endocrine Related Cancer, July 2009, Bioscientifica

    Marta Korbonits

  275. The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes

    Article • European Journal of Endocrinology, May 2009, Bioscientifica

    Marta Korbonits

  276. Recent Clinical and Pathophysiological Advances in Non-Functioning Pituitary Adenomas

    Article • Hormone Research in Paediatrics, April 2009, Karger Publishers

    Marta Korbonits

  277. Association Studies onGhrelinandGhrelin ReceptorGene Polymorphisms With Obesity

    Article • Obesity, April 2009, Wiley

    Marta Korbonits

  278. Shedding light on the intricate puzzle of ghrelin's effects on appetite regulation

    Article • Journal of Endocrinology, March 2009, Bioscientifica

    Marta Korbonits

  279. AIP, a Protein Mutated in Familial Acromegaly, Plays a Role in the Regulation of Cell Proliferation and Shows Cell-Type Specific Subcellular Localisation

    Article • Hormone Research in Paediatrics, January 2009, Karger Publishers

    Marta Korbonits, Dr Sevda Hassan

  280. Assessment of p27 (cyclin‐dependent kinase inhibitor 1B) and aryl hydrocarbon receptor‐interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations

    Article • Clinical Endocrinology, January 2009, Wiley

    Richard Quinton, Marta Korbonits

  281. Familial Isolated Pituitary Adenomas

    Article • touchREVIEWS in Endocrinology, January 2009, Touch Digital Media, Ltd.

    Marta Korbonits

  282. Familial Isolated Pituitary Adenomas

    Article • US Endocrinology, January 2009, Touch Digital Media, Ltd.

    Marta Korbonits

  283. A Genetic Study of the Ghrelin and Growth Hormone Secretagogue Receptor (GHSR) Genes and Stature

    Article • Annals of Human Genetics, January 2009, Wiley

    Marta Korbonits

  284. STOP AKTING TO TREAT ENDOCRINE TUMOURS

    Article • Acta Endocrinologica (Bucharest), January 2009, ACTA Endocrinologica Foundation

    Marta Korbonits

  285. The Yin and Yang of the Ghrelin Gene Products

    Article • Immunology Endocrine & Metabolic Agents - Medicinal Chemistry, December 2008, Bentham Science Publishers

    Marta Korbonits

  286. The potential role of D2 dopamine receptors as a target in the management of neuroendocrine tumors

    Article • Cancer Biology & Therapy, December 2008, Taylor & Francis

    Marta Korbonits

  287. Changes in Adenosine 5′-Monophosphate-Activated Protein Kinase as a Mechanism of Visceral Obesity in Cushing’s Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2008, Endocrine Society

    Marta Korbonits

  288. Ghrelin Receptor Gene Polymorphisms and Body Size in Children and Adults

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2008, Endocrine Society

    Marta Korbonits

  289. Protein western array analysis in human pituitary tumours: insights and limitations

    Article • Endocrine Related Cancer, September 2008, Bioscientifica

    Marta Korbonits

  290. The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2008, Endocrine Society

    Richard Quinton, Marta Korbonits, Dr Sevda Hassan

  291. AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome

    Article • The FASEB Journal, June 2008, Federation of American Societies For Experimental Biology (FASEB)

    Marta Korbonits

  292. Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms

    Article • Endocrine Related Cancer, May 2008, Bioscientifica

    Marta Korbonits

  293. The role of somatostatin analogues in the treatment of neuroendocrine tumours

    Article • Molecular and Cellular Endocrinology, May 2008, Elsevier

    Marta Korbonits

  294. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients

    Article • Nephrology Dialysis Transplantation, April 2008, Oxford University Press (OUP)

    Marta Korbonits

  295. The Orexigenic Effect of Ghrelin Is Mediated through Central Activation of the Endogenous Cannabinoid System

    Article • PLOS One, March 2008, PLOS

    Marta Korbonits

  296. The Role of AMP-Activated Protein Kinase in Obesity

    Article • January 2008, Karger Publishers

    Marta Korbonits

  297. Octreotide and the mTOR Inhibitor RAD001 (Everolimus) Block Proliferation and Interact with the Akt-mTOR-p70S6K Pathway in a Neuro-Endocrine Tumour Cell Line

    Article • Neuroendocrinology, January 2008, Karger Publishers

    Marta Korbonits

  298. Contents / Foreword / Preface

    Article • January 2008, Karger Publishers

    Marta Korbonits

  299. A new variation in the promoter region, the −604 C>T, and the Leu72Met polymorphism of the ghrelin gene are associated with protection to insulin resistance

    Article • International Journal of Obesity, December 2007, Nature

    Marta Korbonits

  300. Metabolic and hormonal changes during the refeeding period of prolonged fasting

    Article • European Journal of Endocrinology, July 2007, Bioscientifica

    Marta Korbonits

  301. Examining the Candidacy of Ghrelin as a Gene Responsible for Variation in Adult Stature in a United Kingdom Population with Type 2 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2007, Endocrine Society

    Marta Korbonits

  302. Ghrelin in neuroendocrine organs and tumours

    Article • Pituitary, May 2007, Springer Science + Business Media

    Marta Korbonits

  303. A mutation and expression analysis of the oncogene BRAF in pituitary adenomas

    Article • Clinical Endocrinology, March 2007, Wiley

    Marta Korbonits, Dr Massimiliano Ruscica

  304. Ghrelin, the peripheral hunger hormone

    Article • Annals of Medicine, January 2007, Taylor & Francis

    Marta Korbonits

  305. Appetite and Metabolic Effects of Ghrelin and Cannabinoids: Involvement of AMP-Activated Protein Kinase

    Article • January 2007, Elsevier

    Marta Korbonits

  306. The Farnesoid X Receptor Is Expressed in Breast Cancer and Regulates Apoptosis and Aromatase Expression

    Article • Cancer Research, October 2006, American Association for Cancer Research (AACR)

    Marta Korbonits

  307. PPAR-? expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-? receptor

    Article • Clinical Endocrinology, September 2006, Wiley

    Marta Korbonits

  308. Macro- and micronutrient losses and nutritional status resulting from 44 days of total fasting in a non-obese man

    Article • Nutrition, September 2006, Elsevier

    Marta Korbonits

  309. Effect of Gastric Bypass and Gastric Banding on Proneurotensin Levels in Morbidly Obese Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2006, Endocrine Society

    Marta Korbonits

  310. Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours

    Article • European Journal of Endocrinology, August 2006, Bioscientifica

    Marta Korbonits

  311. Expanding role of AMPK in endocrinology

    Article • Trends in Endocrinology and Metabolism, July 2006, Elsevier

    Marta Korbonits

  312. Ghrelin and cardiovascular health

    Article • Current Opinion in Pharmacology, April 2006, Elsevier

    Marta Korbonits

  313. Refeeding David Blaine — Studies after a 44-Day Fast

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2005, New England Journal of Medicine (NEJM/MMS)

    Marta Korbonits

  314. Differential gene expression in pituitary adenomas by oligonucleotide array analysis

    Article • European Journal of Endocrinology, June 2005, Bioscientifica

    Marta Korbonits

  315. Enhanced protein kinase B/Akt signalling in pituitary tumours

    Article • Endocrine Related Cancer, June 2005, Bioscientifica

    Marta Korbonits

  316. Fasting and Postprandial Hyperghrelinemia in Prader-Willi Syndrome Is Partially Explained by Hypoinsulinemia, and Is Not Due to Peptide YY3–36Deficiency or Seen in Hypothalamic Obesity Due to Craniopharyngioma

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2005, Endocrine Society

    Marta Korbonits

  317. Cannabinoids and Ghrelin Have Both Central and Peripheral Metabolic and Cardiac Effects via AMP-activated Protein Kinase

    Article • Journal of Biological Chemistry, April 2005, American Society for Biochemistry & Molecular Biology (ASBMB)

    Marta Korbonits

  318. A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas

    Article • PLoS Genetics, January 2005, PLOS

    Marta Korbonits

  319. Striant™ SR: a novel, effective and convenient testosterone therapy for male hypogonadism

    Article • International Journal of Clinical Practice, November 2004, Wiley

    Marta Korbonits

  320. Akting and Cycling: A Tale of the Pituitary

    Article • Hormone Research in Paediatrics, November 2004, Karger Publishers

    Marta Korbonits

  321. Theobromine inhibits sensory nerve activation and cough

    Article • The FASEB Journal, November 2004, Federation of American Societies For Experimental Biology (FASEB)

    Marta Korbonits

  322. The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin

    Article • British Journal of Pharmacology, November 2004, Wiley

    Marta Korbonits

  323. Ghrelin: update on a novel hormonal system

    Article • European Journal of Endocrinology, August 2004, Bioscientifica

    Marta Korbonits

  324. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway

    Article • European Journal of Endocrinology, August 2004, Bioscientifica

    Marta Korbonits

  325. A Comparison of a Novel Testosterone Bioadhesive Buccal System, Striant, with a Testosterone Adhesive Patch in Hypogonadal Males

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2004, Endocrine Society

    Marta Korbonits

  326. Ghrelin?a hormone with multiple functions

    Article • Frontiers in Neuroendocrinology, April 2004, Elsevier

    Marta Korbonits

  327. Elevated Fasting Plasma Ghrelin in Prader-Willi Syndrome Adults Is Not Solely Explained by Their Reduced Visceral Adiposity and Insulin Resistance

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2004, Endocrine Society

    Marta Korbonits

  328. Non-Growth Hormone Endocrine Actions of Ghrelin

    Article • January 2004, Springer Science + Business Media

    Marta Korbonits

  329. Identification of Adrenocorticotropin Receptor Messenger Ribonucleic Acid in the Human Pituitary and Its Loss of Expression in Pituitary Adenomas

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2003, Endocrine Society

    Marta Korbonits

  330. The Kruppel-like transcription factor 6 gene in sporadic pituitary tumours

    Article • Endocrine Related Cancer, September 2003, Bioscientifica

    Marta Korbonits

  331. Reduced expression of the growth hormone and type 1 insulin‐like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor

    Article • Clinical Endocrinology, August 2003, Wiley

    Professor Lou A Metherell, Marta Korbonits

  332. Rapid desensitisation of the GH secretagogue (ghrelin) receptor to hexarelin in vitro

    Article • Journal of Endocrinological Investigation, August 2003, Springer Science + Business Media

    Marta Korbonits

  333. Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours

    Article • Journal of Endocrinology, August 2003, Bioscientifica

    Marta Korbonits

  334. Ghrelin is Released from Rat Hypothalamic Explants and Stimulates Corticotrophin-releasing Hormone and Arginine-vasopressin

    Article • Hormone and Metabolic Research, August 2003, Thieme Publishing Group

    Marta Korbonits

  335. Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency

    Article • Clinical Endocrinology, May 2003, Wiley

    Marta Korbonits

  336. Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei

    Article • Journal of Endocrinology, January 2003, Bioscientifica

    Marta Korbonits

  337. Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours

    Article • Clinical Endocrinology, September 2002, Wiley

    Marta Korbonits

  338. A Variation in the Ghrelin Gene Increases Weight and Decreases Insulin Secretion in Tall, Obese Children

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2002, Endocrine Society

    Marta Korbonits

  339. A Variation in the Ghrelin Gene Increases Weight and Decreases Insulin Secretion in Tall, Obese Children

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2002, Endocrine Society

    Marta Korbonits

  340. Cell Cycle Dysregulation in Human Pituitary Tumours

    Article • Clinical Science, July 2002, Portland Press Ltd.

    Marta Korbonits

  341. The Tissue Distribution of the mRNA of Ghrelin and Subtypes of Its Receptor, GHS-R, in Humans

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2002, Endocrine Society

    Marta Korbonits

  342. Expression of Phosphorylated p27Kip1Protein and Jun Activation Domain-Binding Protein 1 in Human Pituitary Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2002, Endocrine Society

    Marta Korbonits

  343. Expression of Phosphorylated p27Kip1 Protein and Jun Activation Domain-Binding Protein 1 in Human Pituitary Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2002, Endocrine Society

    Marta Korbonits

  344. The Tissue Distribution of the mRNA of Ghrelin and Subtypes of Its Receptor, GHS-R, in Humans

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2002, Endocrine Society

    Marta Korbonits

  345. Optimal Response Criteria for the Human CRH Test in the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2002, Endocrine Society

    Marta Korbonits

  346. Response of Serum Macrophage Migration Inhibitory Factor Levels to Stimulation or Suppression of the Hypothalamo-Pituitary-Adrenal Axis in Normal Subjects and Patients with Cushing's Disease

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2002, Endocrine Society

    Marta Korbonits, Professor Nikolai Petrovsky

  347. Article • Pituitary, January 2002, Springer Science + Business Media

    Marta Korbonits

  348. The Effect of Growth Hormone Secretagogues and Neuropeptide Y on Hypothalamic Hormone Release from Acute Rat Hypothalamic Explants

    Article • Journal of Neuroendocrinology, December 2001, Wiley

    Marta Korbonits

  349. The release of leptin and its effect on hormone release from human pituitary adenomas

    Article • Clinical Endocrinology, June 2001, Wiley

    Marta Korbonits

  350. Expression of 11β-Hydroxysteroid Dehydrogenase Isoenzymes in the Human Pituitary: Induction of the Type 2 Enzyme in Corticotropinomas and Other Pituitary Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2001, Endocrine Society

    Marta Korbonits

  351. Ghrelin, the endogenous ligand to the growth hormone secretagogue receptor — expression in human hypothalamus and pituitary

    Article • Growth Hormone & IGF Research, June 2001, Elsevier

    Marta Korbonits

  352. Expression of 11 -Hydroxysteroid Dehydrogenase Isoenzymes in the Human Pituitary: Induction of the Type 2 Enzyme in Corticotropinomas and Other Pituitary Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2001, Endocrine Society

    Marta Korbonits

  353. Imprinting of the Gsα gene GNAS1 in the pathogenesis of acromegaly

    Article • Journal of Clinical Investigation, March 2001, American Society for Clinical Investigation

    Marta Korbonits

  354. The Expression of the Growth Hormone Secretagogue Receptor Ligand Ghrelin in Normal and Abnormal Human Pituitary and Other Neuroendocrine Tumors1

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2001, Endocrine Society

    Marta Korbonits

  355. Comparison of Somatostatin Analog and Meta-Iodobenzylguanidine Radionuclides in the Diagnosis and Localization of Advanced Neuroendocrine Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2001, Endocrine Society

    Marta Korbonits

  356. The Expression of the Growth Hormone Secretagogue Receptor Ligand Ghrelin in Normal and Abnormal Human Pituitary and Other Neuroendocrine Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2001, Endocrine Society

    Marta Korbonits

  357. Presence of Ghrelin in Normal and Adenomatous Human Pituitary

    Article • Endocrine, January 2001, Springer Science + Business Media

    Marta Korbonits

  358. Article • Pituitary, January 2001, Springer Science + Business Media

    Marta Korbonits

  359. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?

    Article • Clinical Endocrinology, October 2000, Wiley

    Marta Korbonits

  360. Expression of the Pituitary Transcription Factor Ptx-1, But Not That of theTrans-Activating Factor Prop-1, Is Reduced in Human Corticotroph Adenomas and Is Associated with Decreasedα -Subunit Secretion1

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2000, Endocrine Society

    Marta Korbonits

  361. Expression of the Pituitary Transcription Factor Ptx-1, But Not That of the Trans-Activating Factor Prop-1, Is Reduced in Human Corticotroph Adenomas and Is Associated with Decreased  -Subunit Secretion

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2000, Endocrine Society

    Marta Korbonits

  362. Low Expression of the Cell Cycle Inhibitor p27Kip1in Normal Corticotroph Cells, Corticotroph Tumors, and Malignant Pituitary Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1999, Endocrine Society

    Marta Korbonits

  363. Hexarelin as a test of pituitary reserve in patients with pituitary disease

    Article • Clinical Endocrinology, September 1999, Wiley

    Marta Korbonits

  364. The Growth Hormone Secretagogue Hexarelin Stimulates the Hypothalamo-Pituitary-Adrenal Axis via Arginine Vasopressin

    Article • The Journal of Clinical Endocrinology & Metabolism, July 1999, Endocrine Society

    Marta Korbonits

  365. The growth hormone secretagogue receptor

    Article • Growth Hormone & IGF Research, April 1999, Elsevier

    Marta Korbonits

  366. Expression of menin gene mRNA in pituitary tumours

    Article • European Journal of Endocrinology, April 1999, Bioscientifica

    Marta Korbonits

  367. The Effects of GH-Secretagogues on Human Pituitary Cells in Culture and on Rat Hypothalamic Tissue

    Article • January 1999, Elsevier

    Marta Korbonits

  368. Leptin and the thyroid — A puzzle with missing pieces

    Article • Clinical Endocrinology, November 1998, Wiley

    Marta Korbonits

  369. Expression of the Growth Hormone Secretagogue Receptor in Pituitary Adenomas and Other Neuroendocrine Tumors1

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1998, Endocrine Society

    Marta Korbonits

  370. Expression of the Growth Hormone Secretagogue Receptor in Pituitary Adenomas and Other Neuroendocrine Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1998, Endocrine Society

    Marta Korbonits

  371. The Pathophysiology of Circulating Corticotropin-Releasing Hormone-Binding Protein Levels in the Human

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1998, Endocrine Society

    Marta Korbonits

  372. Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary‐adrenal activity

    Article • Clinical Endocrinology, June 1997, Wiley

    Marta Korbonits

  373. Differential stimulation of corticol and dehydropiandrosterone levels by food in obese and normal subjects: relation to body fat distribution

    Article • Clinical Endocrinology, December 1996, Wiley

    Marta Korbonits

  374. Intérêt clinique des neuropeptides GHRH et GHRP

    Article • Archives de Pédiatrie, January 1996, Elsevier

    Marta Korbonits

  375. Diagnosis of Growth Hormone Deficiency in Adults

    Article • Hormone Research, January 1996, Karger Publishers

    Marta Korbonits

  376. The effect of an opiate antagonist on the hormonal changes induced by hexarelin

    Article • Clinical Endocrinology, September 1995, Wiley

    Marta Korbonits

  377. Growth hormone-releasing peptide and its analogues

    Article • Trends in Endocrinology and Metabolism, March 1995, Elsevier

    Marta Korbonits

  378. Determination of Direct Effects of Cytokines on Release of Neuropeptides from Rat Hypothalamus by an in Vitro Method

    Article • January 1993, Elsevier

    Marta Korbonits